kabutan

ReproCELL, Ordinary Profit Forecast for the Fiscal Year Loss Widened in Downward Revision

Thu Feb 12, 2026 3:30 pm JST Earnings

4978 ReproCELL Incorporated 【J-GAAP】

Earnings Report

ReproCELL Incorporated <4978> [TSE Growth] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary loss for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded to a loss of 455 million yen (compared to a loss of 33 million yen in the same period last year).

In addition, the full-year forecast for consolidated ordinary profit/loss has been revised downward from an expected loss of 75 million yen to a loss of 574 million yen (compared to a profit of 45 million yen in the previous period), indicating an expansion in the loss margin.

Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated ordinary profit/loss for the October to March period (second half) has been revised downward from an expected profit of 408 million yen to a loss of 91 million yen (compared to a profit of 148 million yen in the same period of the previous year), turning to a loss outlook.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit significantly dropped to 28 million yen, a 60.0% decrease compared to the same period last year. The operating profit/loss margin drastically worsened from -4.1% in the same period last year to -20.5%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 1,776 -289 58 48 0.6 145.0 Feb 9, 2024 J-GAAP
Apr - Dec, 2024 2,068 -180 -33 -31 -0.3 Feb 13, 2025 J-GAAP
Apr - Dec, 2025 1,609 -676 -455 -458 -4.9 Feb 12, 2026 J-GAAP
YoY -22.2% -275.6% -1,278.8% -1,377.4% -1,326.5%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 2,063 278 408 411 4.3 0 Nov 13, 2025 J-GAAP
Oct - Mar, 2025 New 1,302 -298 -91 -89 -0.9 0 Feb 12, 2026 J-GAAP
Revision Rate -36.9%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 3,037 -268 -75 -75 -0.8 0 May 14, 2025 J-GAAP
Mar, 2026 New 2,276 -844 -574 -575 -6.1 0 Feb 12, 2026 J-GAAP
Revision Rate -25.1% -214.9% -665.3% -666.7% -668.4%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 1,658 19 148 207 2.2 0 May 14, 2025 J-GAAP
Oct - Mar, 2025 Guidance 1,302 -298 -91 -89 -0.9 0 Feb 12, 2026 J-GAAP
YoY -21.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,426 -409 40 -31 -0.4 0 May 13, 2024 J-GAAP
Mar, 2025 2,978 -130 45 103 1.1 0 May 14, 2025 J-GAAP
Mar, 2026 Guidance 2,276 -844 -574 -575 -6.1 0 Feb 12, 2026 J-GAAP
YoY -23.6% -549.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 748 -31 70 73 0.8 -4.1 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 910 50 78 134 1.4 5.5 May 14, 2025 J-GAAP
Apr - Jun, 2025 475 -291 -301 -304 -3.2 -61.3 Aug 13, 2025 J-GAAP
Jul - Sep, 2025 499 -255 -182 -182 -1.9 -51.1 Nov 13, 2025 J-GAAP
Oct - Dec, 2025 635 -130 28 28 0.3 -20.5 Feb 12, 2026 J-GAAP
YoY -15.1% -319.4% -60.0% -61.6% -62.5%

Related Articles